Suppr超能文献

DLG1-AS1/miR-497/YAP1 轴调控甲状腺乳头状癌细胞的进展。

The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression.

机构信息

Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun 130021, China.

Department of Thoracic Surgery, The First Hospital of Jilin University, Changchun 130021, China.

出版信息

Aging (Albany NY). 2020 Nov 16;12(22):23326-23336. doi: 10.18632/aging.104121.

Abstract

The long non-coding RNA (lncRNA), DLG1-AS1, is upregulated in papillary thyroid cancer (PTC) tissues and cell lines. Here, we found that increased expression of DLG1-AS1 caused lymph node metastasis and advanced tumor-node-metastasis (TNM) stage. DLG1-AS1 knockdown inhibited proliferation, invasion, and migration of PTC cells, and impaired tumorigenesis in mouse xenografts. DLG1-AS1 functions as a competing endogenous RNA (ceRNA) for miR-497. Further investigation revealed that DLG1-AS1 regulated yes-associated protein 1 (YAP1; a known target of miR-497) by competitively binding to miR-497. Moreover, inhibition of miR-497 abrogated the inhibitory effects of DLG1-AS1 depletion on PTC cells. These findings demonstrate that the DLG1-AS1-miR-497-YAP1 axis promotes the growth and metastasis of PTC by forming a ceRNA network.

摘要

长链非编码 RNA(lncRNA)DLG1-AS1 在甲状腺乳头状癌(PTC)组织和细胞系中上调。在这里,我们发现 DLG1-AS1 的表达增加导致了淋巴结转移和更晚期的肿瘤-淋巴结-转移(TNM)分期。DLG1-AS1 的敲低抑制了 PTC 细胞的增殖、侵袭和迁移,并损害了小鼠异种移植中的肿瘤发生。DLG1-AS1 作为 miR-497 的竞争性内源性 RNA(ceRNA)发挥作用。进一步的研究表明,DLG1-AS1 通过竞争性结合 miR-497 来调节 yes 相关蛋白 1(YAP1;miR-497 的已知靶标)。此外,抑制 miR-497 消除了 DLG1-AS1 耗竭对 PTC 细胞的抑制作用。这些发现表明,DLG1-AS1-miR-497-YAP1 轴通过形成 ceRNA 网络促进 PTC 的生长和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8af/7746333/0121030fd3a0/aging-12-104121-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验